Es gab 50 kürzliche Insider-Transaktionen für Actinium Pharmaceuticals, Inc. (ATNM), darunter 41 Käufe und 8 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $16.44M und die gesamten Insider-Verkäufe auf $2.15M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Seth Sandesh, Steinhart Richard I, Almenoff June Sherie. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ATNM
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-08-18 |
Seth Sandesh |
Chief Executive Officer |
RSU-Steuereinbehalt |
120,900 |
$1.71 |
$206.74K |
184,481 |
| 2025-03-31 |
Steinhart Richard I |
Director |
Aktienrückgabe |
2,500 |
$59.70 |
$149.25K |
- |
| 2025-03-31 |
Almenoff June Sherie |
Director |
Aktienrückgabe |
50,000 |
$1.71 |
$85.5K |
- |
| 2025-03-31 |
Seth Sandesh |
Chief Executive Officer |
Aktienrückgabe |
33,333 |
$23.49 |
$782.99K |
- |
| 2025-03-31 |
O'loughlin Steve |
Chief Financial Officer |
Aktienrückgabe |
3,333 |
$41.70 |
$138.99K |
- |
| 2025-03-31 |
Nicholson, C. David |
Director |
Aktienrückgabe |
70,311 |
$5.00 |
$351.56K |
- |
| 2025-03-31 |
Shetty Ajit |
Director |
Aktienrückgabe |
72,156 |
$4.96 |
$357.89K |
- |
| 2025-03-31 |
Chell Jeffrey W. |
Director |
Aktienrückgabe |
8,333 |
$9.55 |
$79.58K |
- |
| 2024-11-01 |
Almenoff June Sherie |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-11-01 |
Almenoff June Sherie |
Director |
RSU-Zuteilung |
50,000 |
$1.71 |
$85.5K |
50,000 |
| 2023-12-28 |
Steinhart Richard I |
Director |
RSU-Zuteilung |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2023-12-28 |
Seth Sandesh |
Chief Executive Officer |
RSU-Zuteilung |
984,367 |
$5.00 |
$4.92M |
984,367 |
| 2023-12-28 |
O'loughlin Steve |
Chief Financial Officer |
RSU-Zuteilung |
253,123 |
$5.00 |
$1.27M |
253,123 |
| 2023-12-28 |
Nicholson, C. David |
Director |
RSU-Zuteilung |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2023-12-28 |
Shetty Ajit |
Director |
RSU-Zuteilung |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2023-12-28 |
Chell Jeffrey W. |
Director |
RSU-Zuteilung |
70,311 |
$5.00 |
$351.56K |
70,311 |
| 2022-08-17 |
Seth Sandesh |
Chief Executive Officer |
RSU-Zuteilung |
300,000 |
- |
- |
305,381 |
| 2022-07-01 |
Steinhart Richard I |
Director |
RSU-Zuteilung |
72,156 |
- |
- |
72,156 |
| 2022-07-01 |
Seth Sandesh |
Chief Executive Officer |
RSU-Zuteilung |
827,366 |
- |
- |
827,366 |
| 2022-07-01 |
O'loughlin Steve |
Chief Financial Officer |
RSU-Zuteilung |
256,438 |
$4.96 |
$1.27M |
256,348 |
| 2022-07-01 |
Nicholson, C. David |
Director |
RSU-Zuteilung |
72,156 |
- |
- |
72,156 |
| 2022-07-01 |
Shetty Ajit |
Director |
RSU-Zuteilung |
72,156 |
- |
- |
72,156 |
| 2022-07-01 |
Chell Jeffrey W. |
Director |
RSU-Zuteilung |
72,156 |
- |
- |
72,156 |
| 2021-09-01 |
Steinhart Richard I |
Director |
RSU-Zuteilung |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2021-09-01 |
Seth Sandesh |
Chief Executive Officer |
RSU-Zuteilung |
310,182 |
$6.07 |
$1.88M |
310,182 |
| 2021-09-01 |
O'loughlin Steve |
Chief Financial Officer |
RSU-Zuteilung |
107,463 |
$6.07 |
$652.3K |
107,463 |
| 2021-09-01 |
Nicholson, C. David |
Director |
RSU-Zuteilung |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2021-09-01 |
Shetty Ajit |
Director |
RSU-Zuteilung |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2021-09-01 |
Berger Mark Stanley |
Chief Medical Officer |
RSU-Zuteilung |
67,164 |
$6.07 |
$407.69K |
67,164 |
| 2021-09-01 |
Chell Jeffrey W. |
Director |
RSU-Zuteilung |
18,351 |
$6.07 |
$111.39K |
18,351 |
| 2020-08-12 |
Steinhart Richard I |
Director |
RSU-Zuteilung |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2020-08-12 |
Seth Sandesh |
Chief Executive Officer |
RSU-Zuteilung |
139,062 |
$9.55 |
$1.33M |
139,062 |
| 2020-08-12 |
O'loughlin Steve |
Chief Financial Officer |
RSU-Zuteilung |
59,066 |
$9.55 |
$564.08K |
59,066 |
| 2020-08-12 |
Nicholson, C. David |
Director |
RSU-Zuteilung |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2020-08-12 |
Shetty Ajit |
Director |
RSU-Zuteilung |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2020-08-12 |
Berger Mark Stanley |
Chief Medical Officer |
RSU-Zuteilung |
46,667 |
$9.55 |
$445.67K |
46,667 |
| 2020-08-12 |
Ludwig Dale L. |
Chief Science & Tech. Officer |
RSU-Zuteilung |
50,000 |
$9.55 |
$477.5K |
50,000 |
| 2020-08-12 |
Chell Jeffrey W. |
Director |
RSU-Zuteilung |
8,333 |
$9.55 |
$79.58K |
8,333 |
| 2019-07-12 |
Steinhart Richard I |
Director |
RSU-Zuteilung |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-07-12 |
Seth Sandesh |
CEO |
RSU-Zuteilung |
1,500,000 |
$0.23 |
$348K |
1,500,000 |
| 2019-07-12 |
O'loughlin Steve |
Principal Financial Officer |
RSU-Zuteilung |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Nicholson, C. David |
Director |
RSU-Zuteilung |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-07-12 |
Shetty Ajit |
Director |
RSU-Zuteilung |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-07-12 |
Berger Mark Stanley |
Chief Medical Officer |
RSU-Zuteilung |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Ludwig Dale L. |
Chief Scientific Officer |
RSU-Zuteilung |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Kapur Anil |
Chief Commercial Officer |
RSU-Zuteilung |
400,000 |
$0.23 |
$92.8K |
400,000 |
| 2019-07-12 |
Chell Jeffrey W. |
Director |
RSU-Zuteilung |
250,000 |
$0.23 |
$58K |
250,000 |
| 2019-03-05 |
Berger Mark Stanley |
Chief Medical Officer |
Optionsausübung (ITM) |
3,500 |
$0.60 |
$2.1K |
22,500 |
| 2019-02-21 |
Seth Sandesh |
Chairman & CEO |
Optionsausübung (ITM) |
8,125 |
$0.60 |
$4.88K |
161,458 |
| 2018-12-10 |
Seth Sandesh |
Chairman & CEO |
Informierter Kauf |
10,000 |
$0.44 |
$4.37K |
153,333 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall